Nutra Pharma

Nutra Pharma Net Margin

The Net Profit Margin of Nutra Pharma (NPHC) as of Oct 23, 2026 is -531.37 %. In the previous year, Net Profit Margin was -327.85 % — a change of 62.08% (lower).

Net Margin

-531.37 %

YoY

62.08%

Last updated:

Net Profit Margin of Nutra Pharma is 2025 -531.37 % . Net Profit Margin of Nutra Pharma was 2024 -327.85 % . It decreases by 62.08% lower compared to the previous year.

For Nutra Pharma, the net margin of -531.4% is up versus -13,399.0% a few years ago.

The Nutra Pharma Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
207.16 USD
Jan 1, 2019
-6,314.07 USD
Jan 1, 2020
-6,314.07 USD
Jan 1, 2021
-13,399.01 USD
Jan 1, 2022
1,865.70 USD
Jan 1, 2023
-234.22 USD
Jan 1, 2024
-327.85 USD
Jan 1, 2025
-531.37 USD
The Nutra Pharma Net Margin history
YEARNet MarginYoY
-531.37 %+62.08%
-327.85 %+39.97%
-234.22 %-112.55%
1,865.70 %-113.92%
-13,399.01 %+112.21%
-6,314.07 %0.00%
-6,314.07 %-3,147.95%
207.16 %-106.22%
-3,330.12 %+62.62%
-2,047.81 %+10.63%
-1,850.99 %+334.44%
-426.07 %+1,098.82%
-35.54 %+100.01%
-17.77 %+731.20%
-2.14 %-42.60%
-3.72 %-99.64%
-1,028.95 %+754.93%
-120.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nutra Pharma Stock analysis

What does Nutra Pharma do? Nutra Pharma is an American biotechnology company specializing in researching, developing, and marketing medications for the treatment of neurological, autoimmune, and cancer diseases. The company was founded in 2000 and is headquartered in Coral Springs, Florida. Nutra Pharma initially focused on developing dietary supplements for joint pain and inflammation relief. However, in 2004, the company made a significant breakthrough with the introduction of Nyloxin, a natural pain reliever made from a unique combination of toxins from marine animals such as bees, snakes, and spiders. Nyloxin aims to provide a safe and effective alternative to conventional pain medications like ibuprofen and opioids. In addition to Nyloxin, Nutra Pharma also offers several other products including Sinus Buster, a nasal spray designed to alleviate headaches and migraines, and Pet Pain, a veterinary pain medication for pets. The company is also involved in the research and development of therapeutics for autoimmune diseases like multiple sclerosis and HIV. Nutra Pharma holds patents for its novel drugs and drug candidates, including its ReceptoPharm platform technology currently being utilized in Alzheimer's disease drug development. The company has built a wide network of distribution partners to market its products in the United States and other countries. It also employs an aggressive marketing strategy to raise awareness among physicians, pharmacists, veterinarians, and end consumers. Additionally, Nutra Pharma supports nonprofit organizations dedicated to researching and developing therapeutics for rare and incurable diseases. Overall, Nutra Pharma has become a significant player in the biotechnology industry, developing innovative products and technologies for pain, inflammation, and various diseases. The company has established itself as a valuable partner to distribution partners and nonprofit organizations, benefiting from its expertise and products. Nutra Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nutra Pharma stock

Net Profit Margin of Nutra Pharma is -531.37 % in 2025.

Net Profit Margin of Nutra Pharma changed from -327.85 % to -531.37 %, representing a 62.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Nutra Pharma since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Nutra Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Nutra Pharma

All Key Metrics — Nutra Pharma